MRI software helps determine future Alzheimer’s risk
A commercially available software program that automatically quantifies the extent of brain atrophy on MRI scans can help physicians better determine the risk of developing Alzheimer’s disease in patients with mild cognitive impairment (MCI), according to a study published online October 12 in Neurology.
Researchers from the University of California, San Diego (UCSD) and the University of Gothenburg in Sweden used the software in conjunction with two clinically available measures for predicting the onset of dementia: degree of learning impairment and abnormal biomarker levels of cerebrospinal fluid (CSF).
Medical Imaging Community Rallies Against Device Tax
MITA and its industry partners, including AdvaMed and MDMA, are calling on Congress to pass bipartisan legislation that repeals the medical device tax in a new ad campaign. Learn More
MITA Urges Congress to Reject Reimbursement Cuts
MITA calls on policymakers to protect access to life saving medical imaging technologies. Learn More
Why I Joined Mita – Elekta
Hear from Rajinder Singh Dhada, Vice President of Strategic Partnerships, Elekta, on why his organization joined MITA.
